Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial

NCT01302275 is registered in ClinicalTrials.gov with Søren H. Sindrup as lead sponsor.

NCT NCT01302275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01302275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Søren H. Sindrup
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2011
Completion date
May 31, 2013
Enrollment
117 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral nerve injury, polyneuropathy, postherpetic neuralgia